Cargando…
Development and Validation of an HIV Risk Exposure and Indicator Conditions Questionnaire to Support Targeted HIV Screening
The aim of our study was to develop a Spanish-structured HIV risk of exposure and indicator conditions (RE&IC) questionnaire. People attending to an emergency room or to a primary clinical care center were offered to participate in a prospective, 1 arm, open label study, in which all enrolled pa...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748888/ https://www.ncbi.nlm.nih.gov/pubmed/26844471 http://dx.doi.org/10.1097/MD.0000000000002612 |
_version_ | 1782415195060043776 |
---|---|
author | Elías, María Jesús Pérez Gómez-Ayerbe, Cristina Elías, Pilar Pérez Muriel, Alfonso de Santiago, Alberto Diaz Martinez-Colubi, María Moreno, Ana Santos, Cristina Polo, Lidia Barea, Rafa Robledillo, Gema Uranga, Almudena Espín, Agustina Cano Quereda, Carmen Dronda, Fernando Casado, Jose Luis Moreno, Santiago |
author_facet | Elías, María Jesús Pérez Gómez-Ayerbe, Cristina Elías, Pilar Pérez Muriel, Alfonso de Santiago, Alberto Diaz Martinez-Colubi, María Moreno, Ana Santos, Cristina Polo, Lidia Barea, Rafa Robledillo, Gema Uranga, Almudena Espín, Agustina Cano Quereda, Carmen Dronda, Fernando Casado, Jose Luis Moreno, Santiago |
author_sort | Elías, María Jesús Pérez |
collection | PubMed |
description | The aim of our study was to develop a Spanish-structured HIV risk of exposure and indicator conditions (RE&IC) questionnaire. People attending to an emergency room or to a primary clinical care center were offered to participate in a prospective, 1 arm, open label study, in which all enrolled patients filled out our developed questionnaire and were HIV tested. Questionnaire accuracy, feasibility, and reliability were evaluated. Valid paired 5329 HIV RE&IC questionnaire and rapid HIV tests were performed, 69.3% in the primary clinical care center, 49.6% women, median age 37 years old, 74.9% Spaniards, 20.1% Latin-Americans. Confirmed hidden HIV infection was detected in 4.1%, while HIV RE&IC questionnaire was positive in 51.2%. HIV RE&IC questionnaire sensitivity was 100% to predict HIV infection, with a 100% negative predictive value. When considered separately, RE or IC items sensitivity decreases to 86.4% or 91%, and similarly their negative predictive value to 99.9% for both of them. The majority of people studied, 90.8% self-completed HIV RE&IC questionnaire. Median time to complete was 3 minutes. Overall HIV RE&IC questionnaire test-retest Kappa agreement was 0.82 (almost perfect), likewise for IC items 0.89, while for RE items was lower 0.78 (substantial). A feasible and reliable Spanish HIV RE&IC self questionnaire accurately discriminated all non–HIV-infected people without missing any HIV diagnoses, in a low prevalence HIV infection area. The best accuracy and reliability were obtained when combining HIV RE&IC items. |
format | Online Article Text |
id | pubmed-4748888 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-47488882016-04-01 Development and Validation of an HIV Risk Exposure and Indicator Conditions Questionnaire to Support Targeted HIV Screening Elías, María Jesús Pérez Gómez-Ayerbe, Cristina Elías, Pilar Pérez Muriel, Alfonso de Santiago, Alberto Diaz Martinez-Colubi, María Moreno, Ana Santos, Cristina Polo, Lidia Barea, Rafa Robledillo, Gema Uranga, Almudena Espín, Agustina Cano Quereda, Carmen Dronda, Fernando Casado, Jose Luis Moreno, Santiago Medicine (Baltimore) 4900 The aim of our study was to develop a Spanish-structured HIV risk of exposure and indicator conditions (RE&IC) questionnaire. People attending to an emergency room or to a primary clinical care center were offered to participate in a prospective, 1 arm, open label study, in which all enrolled patients filled out our developed questionnaire and were HIV tested. Questionnaire accuracy, feasibility, and reliability were evaluated. Valid paired 5329 HIV RE&IC questionnaire and rapid HIV tests were performed, 69.3% in the primary clinical care center, 49.6% women, median age 37 years old, 74.9% Spaniards, 20.1% Latin-Americans. Confirmed hidden HIV infection was detected in 4.1%, while HIV RE&IC questionnaire was positive in 51.2%. HIV RE&IC questionnaire sensitivity was 100% to predict HIV infection, with a 100% negative predictive value. When considered separately, RE or IC items sensitivity decreases to 86.4% or 91%, and similarly their negative predictive value to 99.9% for both of them. The majority of people studied, 90.8% self-completed HIV RE&IC questionnaire. Median time to complete was 3 minutes. Overall HIV RE&IC questionnaire test-retest Kappa agreement was 0.82 (almost perfect), likewise for IC items 0.89, while for RE items was lower 0.78 (substantial). A feasible and reliable Spanish HIV RE&IC self questionnaire accurately discriminated all non–HIV-infected people without missing any HIV diagnoses, in a low prevalence HIV infection area. The best accuracy and reliability were obtained when combining HIV RE&IC items. Wolters Kluwer Health 2016-02-08 /pmc/articles/PMC4748888/ /pubmed/26844471 http://dx.doi.org/10.1097/MD.0000000000002612 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. http://creativecommons.org/licenses/by-nc-sa/4.0 |
spellingShingle | 4900 Elías, María Jesús Pérez Gómez-Ayerbe, Cristina Elías, Pilar Pérez Muriel, Alfonso de Santiago, Alberto Diaz Martinez-Colubi, María Moreno, Ana Santos, Cristina Polo, Lidia Barea, Rafa Robledillo, Gema Uranga, Almudena Espín, Agustina Cano Quereda, Carmen Dronda, Fernando Casado, Jose Luis Moreno, Santiago Development and Validation of an HIV Risk Exposure and Indicator Conditions Questionnaire to Support Targeted HIV Screening |
title | Development and Validation of an HIV Risk Exposure and Indicator Conditions Questionnaire to Support Targeted HIV Screening |
title_full | Development and Validation of an HIV Risk Exposure and Indicator Conditions Questionnaire to Support Targeted HIV Screening |
title_fullStr | Development and Validation of an HIV Risk Exposure and Indicator Conditions Questionnaire to Support Targeted HIV Screening |
title_full_unstemmed | Development and Validation of an HIV Risk Exposure and Indicator Conditions Questionnaire to Support Targeted HIV Screening |
title_short | Development and Validation of an HIV Risk Exposure and Indicator Conditions Questionnaire to Support Targeted HIV Screening |
title_sort | development and validation of an hiv risk exposure and indicator conditions questionnaire to support targeted hiv screening |
topic | 4900 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748888/ https://www.ncbi.nlm.nih.gov/pubmed/26844471 http://dx.doi.org/10.1097/MD.0000000000002612 |
work_keys_str_mv | AT eliasmariajesusperez developmentandvalidationofanhivriskexposureandindicatorconditionsquestionnairetosupporttargetedhivscreening AT gomezayerbecristina developmentandvalidationofanhivriskexposureandindicatorconditionsquestionnairetosupporttargetedhivscreening AT eliaspilarperez developmentandvalidationofanhivriskexposureandindicatorconditionsquestionnairetosupporttargetedhivscreening AT murielalfonso developmentandvalidationofanhivriskexposureandindicatorconditionsquestionnairetosupporttargetedhivscreening AT desantiagoalbertodiaz developmentandvalidationofanhivriskexposureandindicatorconditionsquestionnairetosupporttargetedhivscreening AT martinezcolubimaria developmentandvalidationofanhivriskexposureandindicatorconditionsquestionnairetosupporttargetedhivscreening AT morenoana developmentandvalidationofanhivriskexposureandindicatorconditionsquestionnairetosupporttargetedhivscreening AT santoscristina developmentandvalidationofanhivriskexposureandindicatorconditionsquestionnairetosupporttargetedhivscreening AT pololidia developmentandvalidationofanhivriskexposureandindicatorconditionsquestionnairetosupporttargetedhivscreening AT barearafa developmentandvalidationofanhivriskexposureandindicatorconditionsquestionnairetosupporttargetedhivscreening AT robledillogema developmentandvalidationofanhivriskexposureandindicatorconditionsquestionnairetosupporttargetedhivscreening AT urangaalmudena developmentandvalidationofanhivriskexposureandindicatorconditionsquestionnairetosupporttargetedhivscreening AT espinagustinacano developmentandvalidationofanhivriskexposureandindicatorconditionsquestionnairetosupporttargetedhivscreening AT queredacarmen developmentandvalidationofanhivriskexposureandindicatorconditionsquestionnairetosupporttargetedhivscreening AT drondafernando developmentandvalidationofanhivriskexposureandindicatorconditionsquestionnairetosupporttargetedhivscreening AT casadojoseluis developmentandvalidationofanhivriskexposureandindicatorconditionsquestionnairetosupporttargetedhivscreening AT morenosantiago developmentandvalidationofanhivriskexposureandindicatorconditionsquestionnairetosupporttargetedhivscreening |